Live
- They always want me to win, and now I feel lucky to have been offered a story like ‘Zebra’: Satyadev Kancharana
- ‘Democracy first, humanity first’: PM Modi in Guyana's parliament on two countries' similarities
- PKL Season 11: Telugu Titans register third straight win to top standings
- Is Pollution Contributing to Your COPD?
- NASA Unveils Underwater Robots for Exploring Jupiter's Moons
- Additional Central forces arrive in violence-hit Manipur
- AR Rahman and Saira Banu’s Divorce: Legal Insights into Common Issues in Bollywood Marriages
- 82.7 pc work completed in HPCL Rajasthan Refinery area: official
- Curfew relaxation extended in 5 Manipur districts on Friday
- Tab scam prompts Bengal govt to adopt caution over fund disbursement
'Heterologous Booster Dose' enhances protection against Covid: AIG report
‘Heterologous Booster Dose’ enhances protection against Covid: AIG report
A study taken up by the AIG Hospitals found that after two doses of vaccination, having a booster dose of a different company would enhance the protection against Omicron variants.
Hyderabad: A study taken up by the AIG Hospitals found that after two doses of vaccination, having a booster dose of a different company would enhance the protection against Omicron variants.
The Hospital tried a booster dose of a different company, what they call this phenomenon is 'Heterologous booster dose' with Corbevax (by BiologicalE) on about 250 patients and it showed that the immunity levels tremendously increased in the patients.
The study titled 'Heterologous Booster Dose with CORBEVAX Following Primary Vaccination with COVISHIELD has shown that it enhances Protection against SARS-CoV-2' was published in the high-impact factor journal 'Vaccines,' said AIG Hospital Chairman Dr D Nageshwar Reddy.
